NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 922 filers reported holding NOVARTIS A G in Q2 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $4,000 | -75.0% | 50 | -75.0% | 0.00% | -75.0% |
| Q1 2018 | $16,000 | -5.9% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $17,000 | -69.1% | 200 | -68.6% | 0.00% | -71.4% |
| Q3 2017 | $55,000 | +3.8% | 637 | 0.0% | 0.01% | -6.7% |
| Q2 2017 | $53,000 | +120.8% | 637 | +97.8% | 0.02% | +87.5% |
| Q1 2017 | $24,000 | +4.3% | 322 | 0.0% | 0.01% | -11.1% |
| Q4 2016 | $23,000 | -43.9% | 322 | -38.3% | 0.01% | -50.0% |
| Q3 2016 | $41,000 | +41.4% | 522 | +49.1% | 0.02% | +50.0% |
| Q2 2016 | $29,000 | +16.0% | 350 | -22.0% | 0.01% | +9.1% |
| Q1 2016 | $25,000 | +47.1% | 449 | +124.5% | 0.01% | +22.2% |
| Q4 2015 | $17,000 | -5.6% | 200 | 0.0% | 0.01% | -10.0% |
| Q3 2015 | $18,000 | -10.0% | 200 | 0.0% | 0.01% | -9.1% |
| Q2 2015 | $20,000 | -48.7% | 200 | -50.0% | 0.01% | 0.0% |
| Q1 2015 | $39,000 | +105.3% | 400 | +100.0% | 0.01% | 0.0% |
| Q4 2014 | $19,000 | 0.0% | 200 | 0.0% | 0.01% | -8.3% |
| Q3 2014 | $19,000 | +5.6% | 200 | 0.0% | 0.01% | +9.1% |
| Q2 2014 | $18,000 | – | 200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |